Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)

Summary

The purpose of this study is to evaluate the safety and effectiveness of an experimental 20% betulinic acid ointment (BA ointment) as a treatment for dysplastic nevi with the potential to transform into melanoma.

Timeline

Start

2006-01

Primary completion

2015-12

Completion

2015-12

Outcome

Outcome not reported

Stopped (Enrollment): “No subjects enrolled”

Drugs

Indications